Search Results

Containing any of the words

Only of the type

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Arm, Parallel-Group Study in Pediatric Subjects Aged 10 Through 17 Years to Evaluate the Efficacy and Safety of BG00012 and BIIB017 for the Treatment of Relapsing-Remitting Multiple Sclerosis Drug Clinical Trial

A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). Drug Clinical Trial

A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). Drug Clinical Trial

Rules and Protocols are Applied in Food Facilities in Cases of Food Poisoning or Suspected Cases Regulations

SFDA Addresses Dexcom Glucose Monitoring Device Defect, Confirms Limited Distribution in Saudi Arabia News

SFDA Signs MOU for Cooperation with College Dublin in the Fields of Food and Microbiological Monitoring Risk News

Kenyan Ambassador Visit to SFDA News

U.S. FDA issues an early communication about ongoing data review of three Cholesterol lowering agents News

SFDA Approves the Registration of “Pemazyre” for the Treatment of Bile Duct Cancer in Adults News

Saudi Food and Drug Authority would like to warn from the existence of a counterfeit Endodontic Files Awareness Article